Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Understanding the Cost and Funding of Gene Ther...
By
HEOR Staff Writer
July 31, 2024
Introduction Gene therapy is rapidly transforming the treatment landscape for rare diseases. With innovations like CAR T-cell therapy and CRISPR...
Cost-Effectiveness of Immune Checkpoint Inhibitors in Advanced Endometrial Ca...
Revealing the Hidden Impact: Family Spillover Effects
From Skepticism to Support: Healthcare Providers’ Acceptance of Digital...
Genome-Wide Sequencing in Diagnosing Rare Diseases: Clinical and Economic Imp...
Antenatal HCV Screening in Egypt: Paving the Path to Elimination
Health Economic Assessment of Nirsevimab for Respiratory Syncytial Virus in H...
The Economic Burden of Liver Transplantation for Hepatitis B in Italy
Impact of Brain Cancer Care Coordinators on Healthcare Utilisation
Challenges and Opportunities in Educating the Public About Childhood Arthriti...
Access to Essential Medicines for Rheumatic Diseases in Children
Economic Burden of Juvenile Idiopathic Arthritis in Spain
Biosimilars in Juvenile Arthritis Management: Connecting the Treatment Continuum
« Previous
1
…
24
25
26
27
28
…
48
Next »